Use of treatment pathway improves neoadjuvant chemotherapy use in muscle-invasive bladder cancer. Faraj KS, Navaratnam AK, Eversman S, Elias L, et al. Int Urol Nephrol 2021 Jan 3. pii: 10.1007/s11255-020-02752.

Read + Share

Amedeo Smart

Independent Medical Education

Faraj KS, Navaratnam AK, Eversman S, Elias L, et al. Use of treatment pathway improves neoadjuvant chemotherapy use in muscle-invasive bladder cancer. Int Urol Nephrol 2021 Jan 3. pii: 10.1007/s11255-020-02752.
PMID: 33389510